GRI Bio GRI
NASDAQ GRI
$1.47 +0.01 (+0.68%)
At close: Oct 21, 2026 · 4:00 PM EDT

GRI Bio (GRI) Debt Ratio (2020 - 2022)

Updated

GRI Bio's (GRI) Debt Ratio stood at 1.57 in Q4 2022.

Analysis

GRI Bio (GRI) Debt Ratio (2020 - 2022) Analysis & Trends

  • Across earlier years, Debt Ratio came in at 0.06 in FY2020.
  • The Q4 2022 figure is the lowest quarterly Debt Ratio since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 GRI Bio 2.65 Mn -31.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.57
Dec 31, 2020 0.06
API Access

GRI Bio Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=GRI&period=max&api_key=YOUR_API_KEY